Cytoreductive surgery for the management of stage IV ovarian cancer

Free article

Editorial

P E Schwartz. Gynecol Oncol. 1997 Jan.

Free article

. 1997 Jan;64(1):1-3.

doi: 10.1006/gyno.1996.4586.

No abstract available

Comment on

Effect of surgical debulking on survival in stage IV ovarian cancer.
Liu PC, Benjamin I, Morgan MA, King SA, Mikuta JJ, Rubin SC. Liu PC, et al. Gynecol Oncol. 1997 Jan;64(1):4-8. doi: 10.1006/gyno.1996.4396. Gynecol Oncol. 1997. PMID: 8995539
Stage IV ovarian cancer: impact of surgical debulking.
Curtin JP, Malik R, Venkatraman ES, Barakat RR, Hoskins WJ. Curtin JP, et al. Gynecol Oncol. 1997 Jan;64(1):9-12. doi: 10.1006/gyno.1996.4550. Gynecol Oncol. 1997. PMID: 8995540
Prognostic significance of residual disease in patients with stage IV epithelial ovarian cancer.
Munkarah AR, Hallum AV 3rd, Morris M, Burke TW, Levenback C, Atkinson EN, Wharton JT, Gershenson DM. Munkarah AR, et al. Gynecol Oncol. 1997 Jan;64(1):13-7. doi: 10.1006/gyno.1996.4540. Gynecol Oncol. 1997. PMID: 8995541